Extramedullary leukemia relapse after allogeneic stem cell transplantation: a novel mechanism of immune escape?

Konstantinos Gkirkas1, Maria Stamouli2, Angeliki Karagiannidou2

  • 12nd Department of Internal Medicine, Propaedeutic, ATTIKON General University Hospital, National & Kapodistrian University of Athens.

Immunotherapy
|May 22, 2020
PubMed

Background: Relapse is a significant cause of treatment failure after allogeneic stem cell transplantation. In many cases relapse occurs when leukemic cells escape from immune surveillance. Methods & results: In the setting of haploidentical transplantation, immune escape is usually the result of the loss of the mismatched haplotype from leukemic cells, while downregulation of HLA-expression has been postulated as a significant cause of immune escape after transplantation with the use of HLA-matched donors. We observed that patients with acute leukemia who relapse at the time of active graft-versus-host-disease, usually develop extramedullary leukemia while they remain free of leukemia in peripheral blood and bone marrow. Conclusion: Our observation points toward a novel mechanism of immune escape which is microenvironment-specific.